SAPIEN 3
Commercial- Indications
- Aortic stenosis
Company intelligence / Profile preview
Edwards Lifesciences has multiple FDA-approved and CE-marked products for transcatheter and surgical heart valve replacement/repair and advanced hemodynamic monitoring. Its Sapien transcatheter aortic heart valves are widely used globally for patients with severe aortic stenosis at various surgical risk levels. The company continues to expand its portfolio through acquisitions and internal R&D.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Edwards Lifesciences.